GSK3B and breast carcinoma: Furthermore, EGCG exhibited inhibitory effects on glycogen synthase kinase-3β (GSK-3β) phosphorylation while promoting GSK-3β expression and reducing β-catenin levels in CRC and breast cancer cell lines [280].